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特　別　講　演　会　要　旨
　2011年 11月から 2012年 5月までの間に東北医学会主催で行われた特別講演会は
次のとおりです．
 1.　2011年 11月 10日（木）行動医学分野担当
Emeran A. Mayer, M.D., Professor of Medicine and 
Psychiatry : Center for Neurobiology of Stress, Divi-
sion of Digestive Diseases, David Geffen School of Medi-
cine at UCLA, Los Angeles
“Brain Imaging in Functional Gastrointestinal Dis-
orders”
要旨 : Functional gastrointestinal （GI） disorders such as 
irritable bowel syndrome （IBS） and functional dyspepsia （FD） 
are common, have a significant effect on health related quality 
of life of affected patients and are responsible for considerable 
health care expenditures. Yet, despite decades of worldwide 
research, a general accepted pathophysiology has not been 
established, and drug development efforts have generally been 
disappointing. There are at least three factors contributing to 
this situation : 1） The almost exclusive reliance on subjective 
symptom based diagnoses, which has resulted in a heteroge-
neous group of patients classified under a particular syndrome 
（e.g. IBS, FD）, with artificial separation between multiple 
upper and lower “syndromes”. 2） The erroneous assump-
tion that subjective symptoms, such as pain and discomfort are 
generated by a linear transmission of altered gastrointestinal 
signals to the brain. 3） The nearly exclusive focus on a spe-
cific gut related pathology explaining the symptom com-
plex. Functional and structural brain imaging in functional GI 
disorder research is based on the following concepts : 1） 
Spontaneous symptoms in these disorders are a multidimen-
sional experience, with interoceptive, affective, cognitive and 
memory based components. 2） Using multimodal brain 
imaging techniques, it is possible to deconstruct the complex 
pain experience, and the associated autonomic nervous system 
responses into its individual components （“endopheno-
types”）. Functional brain imaging studies have identified 
alterations in the responsiveness of certain brain regions 
（including insula and anterior cingulate cortex） in response to 
visceral and psychological stimuli in both IBS and FD 
patients. Connectivity analyses have shown alterations in 
the effective connectivity between such regions, and have 
identified altered connectivity patterns within interoceptive, 
emotional arousal and cortico-limbic-pontine circuits. Some 
studies have shown correlations of these alterations and gene 
polymorphisms. More recent studies into cortical morpho-
metric alterations, have identified structural grey matter alter-
ations in some of these same brain regions, and studies into 
white matter abnormalities are showing alterations in white 
matter tracts connecting affected regions. The activity and 
connectivity of some of these circuits can be modulated by 
pharmacological probes, such as CRF-R1 antagonism and 
acute tryptophan depletion. Based on the data available today 
from brain imaging studies performed in IBS and FD, and from 
brain imaging studies in the field of pain and psychiatric dis-
eases, it is suggested that a） patterns of brain imaging abnor-
malities distinguish healthy control subjects from patients ; b） 
subgroups of patients exist within symptom criteria defined 
syndromes ; c） similar subgroups can be identified in IBS and 
FD patients. These findings have important implications for 
drug development efforts including target identification and 
better clinical trial designs.
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 （文責 : 福土　審）
 2.　2011年 11月 11日（金）病理診断学分野担当
Gail S. Prins, PhD : Departments of Urology and Phys-
iology & Biophysics University of Illinois at Chicago
“Developmental Reprogramming by Natural and 
Environmental Estrogens : Implications for Pros-
tate Disease”
要旨 : While early-life estrogens are thought to play a 
physiological role in normal prostate gland development and 
function, inappropriate estrogenic exposures during develop-
ment either in timing, dose or type can reprogram the gland 
and increase susceptibility to abnormal growth with aging 
including carcinogenesis. Our research using a rat model 
indicates that estrogen imprinting of the prostate is mediated 
through structural reorganization of the gland early in life as 
well as epigenomic reprogramming that together permits life-
long memory of the inappropriate developmental exposures.　
To assess whether the human prostate may be similarly repro-
grammed during early life by hormones and endocrine disrupt-
ing chemicals （EDCs）, we have developed in vitro and in vivo 
models using normal human prostate stem/progenitor cells.　
Cultured prostaspheres composed of prostate stem and early-
stage progenitor cells express robust levels of ERα, ERβ and 
GPR30 and exhibit a proliferative response with increased 
stem cell side populations to low-dose estradiol and the 
bisphenol A （BPA）, an EDC with estrogenic actions. Fur-
ther, developmental exposure of recombinant human/rat pros-
tates to BPA in vivo results in increased incidence of estrogen-
induced PIN and prostate cancer. Together these findings 
indicate that early stage progenitor and stem cells in the 
human prostate may be direct targets of EDCs and suggest 
that humans may be susceptible to prostate disease in a man-
ner similar to the rodent models.
   （文責 : 笹野公伸）
 3.　2011年 11月 11日（金）放射線科担当
Robert L. Vogelzang MD : Professor of Radiology 
Northwestern University Medical School Chicago, IL
“Treatment of High-Flow AVMs Using The Trans-
venous Approach”
要旨 : Arteriovenous malformations （AVMs） are extremely 
problematic, symptomatic but very uncommon congenital 
lesions which can affect any part of the body. The symptoms 
produced by these lesions are highly varied but may include 
venous ulceration, hemorrhage and high output cardiac failure. 
Historically, attempts at surgical resection have inevitably 
been met with extremely limited success and high rates of 
recurrence. Indeed, many operative approaches involve wide 
excisions and amputations and still with persistence of lesions 
at resection margins.
In the past 30 years interventional endovascular techniques 
have been promoted for the treatment of vascular malforma-
tions. These have been somewhat successful, however for 
the most part, the common agents used̶particles, coils and 
other large occlusive agents have not been successful at per-
manently eliminating or curing the lesions.　A careful reading 
of the literature and clinical experience with these patients 
points out that most authors describe “control” of lesions but 
not cure.
In the 1980s Dr. Wayne Yakes of Denver, Colorado first 
described the curative benefits of intra-arterial ethanol for the 
cure of difficult and problematic high flow arteriovenous mal-
formations. Pure ethanol is an extremely toxic agent and as a 
result, this method was difficult, labor intensive and very 
dependent on meticulous technique to produce the results 
claimed by Yakes. Ethanol was infrequently successful in the 
hands of the vast majority of practitioners who saw small num-
bers of AVMs per year and there were numerous reports of 
serious injuries and death from the inappropriate use of alcohol 
largely because it was not introduced with the appropriate cau-
tion or in the right location.
More recently, we have discovered that a considerable num-
ber of high flow AVMs can be treated via the transvenous 
route in a simple method that produces outstanding results 
and very low complication rates. This route affords a mea-
sure of safety and simplicity that has simply not been previ-
ously available.
The basic principles of this method include :
1）　Identification of a proper and suitable AVM. This 
includes AVMs in which the largest outflow component 
is a large vein itself, or one in which there is a domi-
nant outflow vein
2）　The use of direct puncture and “packing” of the venous 
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outflow structure with coils
3）　Control of the residual malformation with the use of 
small amounts of ethanol introduced into the coil pack.
The results of these interventions have been remarkable ;  
many AVMs including extensive large and impossible to treat 
lesions have been cured in one or two steps. This lecture 
will demonstrate the method and show early and late results 
in a large series of such lesions and patients treated over the 
past 10 years.
 （文責 : 高橋昭喜）
 4.　2011年 11月 29日（火）応用脳科学研究分野
Dr. Harry R. MOODY : Office of Academic Affairs, 
AARP
“The Ethics of Autonomy : A Helpful American 







































にとって “生きることの意味は『生命の環』（the great cir-
cle of life）の中にある”という世界観の再発見を象徴する
ものでもある．
 （文責 : 川島隆太）
 5.　2011年 12月 9日（金）感染病態学分野担当
凌虹教授 : Harbin Medical University
“VNTR genotypes and the resistence of the Myco-









日に “VNTR genotypes and the resistance of the Mycobacte-
ria tuberculosis”の講演を行った．既に我々の共同研究　J. 



















 （文責 : 服部俊夫）
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 6.　2011年 12月 21日（水）公衆衛生学分野担当
Ichiro Kawachi : Professor of Social Epidemiology, 
Department of Society, Human Development & Health, 





























 （文責 : 辻　一郎）
 7.　2012年 1月 13日（金）感染病態学分野担当
Dr. Talitha Lea V. Lacuesta : SACCL/SLH
“Dengue Case Classification and Management”
























WHO新診断基準では臨床症状で診断する場合 dengue with 




 （文責 : 服部俊夫）
 8.　2012年 2月 6日（月）腎・高血圧・内分泌学分野担当
Jacqui Webster, Ph.D. : The George Institute for 
International Health, Co-ordinator, Australian Division of 
World Action on Salt and Health
“Key elements of effective interventions to reduce 
population salt intake”

































 （文責 : 佐藤恵美子）
 9.　2011年 2月 7日（火）病理診断学分野担当
Nirukshi Samarajeewa1,2, Evan R. Simpson1,3, 
Kristy A. Brown1,2 : 1Prince Henry’s Institute, Clayton, 
Victoria ; 2Department of Physiology, Monash Univer-
sity, Clayton, Victoria ; 3Department of Biochemistry and 
Molecular Biology, Monash University, Clayton, Victoria
“Understanding the cAMP response element 
（CRE）-dependent regulation of aromatase in post-
menopausal breast cancer”
要旨 : The majority of postmenopausal breast cancers are 
oestrogen-dependent. Tumour-derived factors such as pros-
taglandin E2 （PGE2） stimulate the CREB-dependent regula-
tion of aromatase by increasing the activity of its promoter II 
（PII）, leading to the increased biosynthesis of oestrogens in 
adipose stromal cells （ASCs）. We have previously demon-
strated that the CREB co-activator CRTC2 can bind and acti-
vate PII via cAMP response elements （CREs） and that its 
subcellular localisation is regulated by PGE2. There are 
three known members of the CRTC family （CRTC1-3） and 
the regulation of aromatase expression by other CRTC mem-
bers is poorly understood. HIF-1α is a key mediator of 
hypoxic responses in tumours and we have identified a puta-
tive HIF-response element which overlaps with the proximal 
CRE of aromatase PII. PGE2 has been shown to stabilise 
HIF-1α independent of oxygen availability in human colon and 
prostate cancer cells. However, the regulation of aromatase 
expression by HIF-1α in breast cancer is not yet character-
ised. This study aimed to characterise the role of CRTCs and 
HIF-1α in the activation of aromatase PII.
The subcellular localisation of endogenously expressed 
CRTCs was examined by immunofluorescence （IF）/confocal 
imaging after treatment with PGE2. PGE2 resulted in the 
nuclear translocation of cytoplasmic CRTC2 and CRTC3.　
CRTC1 was constitutively peri-nuclear. Reporter assays 
were performed to assess the effect of the CRTCs on PII 
activity.　Basal PII activity was significantly increased with all 
CRTCs and forskolin （FSK） and phorbol ester （PMA）, to 
mimic PGE2, resulted in a further significant increase in PII 
activity with CRTC2 and CRTC3. The highest fold induction 
with treatment was observed for CRTC2. ChIP analysis con-
firmed that CRTCs bind to PII under resting conditions. To 
determine the contribution of the distal and proximal CREs to 
CRTC-mediated activity of PII, reporter assays were per-
formed using CRE-mutants. Results suggest that both CREs 
are essential for the maximal induction of PII activity. The 
subcellular localisation of endogenously expressed HIF-1α 
was examined by IF/confocal imaging after treatment with 
PGE2 and dimethyloxallyl glycine （DMOG）, which stabilises 
HIF-1α under normal oxygen tension. Both PGE2 and 
DMOG resulted in nuclear accumulation of HIF-1α. ChIP 
analysis confirmed that HIF-1α binding to PII is increased 
with PGE2 and DMOG treatments. Reporter assays were 
performed to assess the effect of FSK/PMA and DMOG treat-
ments on PII activity after co-transfection with HIF-1α and/or 
CREB1. PII activity was significantly increased in HIF-1α 
transfected cells in the presence of FSK/PMA and DMOG, and 
treatment with both FSK/PMA and DMOG led to a further 
significant increase in PII activity. Interestingly, cells trans-
fected with both HIF-1α and CREB1 resulted in a co-operative 
effect on PII activity with both FSK/PMA and DMOG. Muta-
tion of proximal CRE abolished the HIF-1α/DMOG mediated 
activation of PII. Hence, it is possible that HIF-1α contrib-
utes to the maximal induction of aromatase PII via binding to 
the proximal CRE in response to tumour-derived factors such 
as PGE2 in co-operation with CREB1. In conclusion, this 
study identifies CRTCs and HIF-1α as modulators of aroma-
tase PII in breast ASCs, thereby furthering our understanding 
of the complex nature of aromatase regulation in postmeno-
pausal breast cancer. Together with our on-going studies on 
the role of AMPK in the regulation of breast aromatase, this 
work provides another link between dysregulated metabolism 
and breast cancer.
 （文責 : 笹野公伸）
10.　2012年 2月 20日（月）病態液性制御学分野・移植・
再建・内視鏡外科
Prof. Seth Karp : Director, Vanderbilt Transplant Cen-
ter, Division of Hepatobiliary Surgery and Liver Trans-
plantation, Vanderbilt University Medical Center
“米国の肝臓，膵臓，腎臓移植医療”












減少傾向であり，特に 2年前に Bostonと Coloradoで生体
ドナーの死亡例がありこのことが生体肝移植の減少に拍車
をかけている．また近年心停止後のドナー（Donor after 

















本においては生体肝移植での small for sizeが問題点で有
り，肝再生促進物質が使えると生存率が上がることが期待
される．
 （文責 : 川岸直樹，阿部高明）
11.　2012年 4月 10日（火）医用画像工学分野担当
Katsuyuki Taguchi : Assistant Professor of Radiology, 





































 （文責 : 森　一生）
12.　2011年 4月 11日（水）臨床生理検査学分野担当
Pieter P de Tombe : Department of Cell and Molecular 
Physiology, Loyola University Chicago




































 （文責 : 三浦昌人）
13.　2012年 4月 16日（月）心臓血管外科学分野担当
Dr. Roberto Lorusso : Community Hospital, Piazzale 
Spedali Civili
“Postoperative Degeneration of Bioprosthetic Valve 
for Aortic Valve Replacement : Preventable or 
Inevitable ?”
Structural valve degeneration （SVD）following implanta-
tion of a heterologous tissue valve has been represented a 
major issue in postoperative outcome of patients undergoing 
cardiac valve replacement. Mechanisms underlying such a 
phenomenon are not fully understood, and range from pros-
thetic-related to patient-related factors.
Characteristics of the artificial valve tissue, hemodynamic 
performance, and patient/prosthesis geometrical and anatomi-
cal relationships have been shown to play a critical role in 
determining an unfavourable outcome with regards to SVD 
occurrence.
Recent clinical and experimental findings have gradually 
highlighted the impact of patient-related factors in the mecha-
nisms favouring tissue valve degeneration. Atherosclerosis 
has been shown to act as a predisposing milieu for anticipated 
postoperative bioprosthetic dysfunction. A recent multicen-
tre retrospective study conducted by our group has recently 
shown that diabetes mellitus also represents an extremely 
important negative determinant of late biological valve out-
come, particularly in patients with poor control of the meta-
bolic disease and treated with insulin therapy. Metabolic 
syndrome and other conditions compromising the integrity of 
the blood and endothelium have been also documented to pre-
dispose to accellerated bioprosthetic degeneration and SVD 
appearance.
Our group is fully committed to enhance and improve the 
understanding of the precise factors and mechanisms underly-
ing postoperative SVD of biological valve substitute for cardiac 
valve replacement, and is also extremely engaged in pre-clini-
cal and clinical investigations to assess whether any modyfi-
able procedure （from surgical to pharmacological interven- 
tion） might provide any protection or limitation against post-
operative SVD. Our findings about the use of statins in ani-
mals to smooth the postoperative degeneration of biological 
valve tissue appears promising, and other studies are ongoing 
to provide further insights about the contributions of peculiar 
atherosclerotic-related conditions and potential treatment sto 
prevent or limit biological valve SVD.
 （文責 : 齋木佳克）
14.　2012年 4月 23日（月）整形外科学分野担当
Professor Vo Van Thahn : Spinal Surgery Department 
A Hospital for Trauma-Orthopedics, Vietnam
“Activities of Hospital for Trauma-Orthopedics and 
how to take care of poor scoliotic patients in 
Vietnam”
要旨 : ベトナム，ホーチミン市にある Hospital for Trau-
















 （文責 : 中村　豪）
15.　2012年 5月 11日（金）医療安全推進室担当
Ray Goellner, Pharm. D : Clinical Assistant Professor 
Pharmacy Practice and Science, The University of Ari-
zona Colledge of Pharmacy
“アメリカの病院における医療安全の為の取り組み
─Medication Safety in Dispensing and Ad min is tra-
tion─”
































 （文責 : 藤盛啓成）
16.　2012年 5月 21日（月）整形外科学分野担当
Mr. Adesegun Abudu, FRCS : Department of Ortho-
paedics and Musculoskeletal Oncology, Royal Orthopae-
dic Hospital, Birmingham, UK
“Endoprosthetic Replacements of Major Bones-
Lessons learned over 40 years”


































 （文責 : 保坂正美）
